Impact of hyperprolactinemia in a patient with polyautoimmunity.

Journal: Clinical case reports
Published Date: Nov 9, 2018

Abstract

Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly raised levels of prolactin (20-40 ng/mL) and administration of dopaminergic agonists.

Authors

  • Manuel Rojas
    Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.
  • Yhojan Rodríguez
    Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.
  • Carolina Ramírez-Santana
    Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.
  • Juan-Manuel Anaya
    Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals